Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-063937
Filing Date
2019-11-14
Accepted
2019-11-14 11:05:17
Documents
1
Period of Report
2019-11-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm1922795d2_4.html 4  
1 OWNERSHIP DOCUMENT tm1922795d2_4.xml 4 4055
  Complete submission text file 0001104659-19-063937.txt   5667
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address PO BOX 816 NEWTOWN PA 08540
Business Address
Cook Jodi A (Reporting) CIK: 0001791004 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 191217702